Literature DB >> 16499827

Intrathecal analgesic drug therapy.

Alan Farrow-Gillespie1, Kimberly M Kaplan.   

Abstract

Intrathecal analgesic infusion therapy through an implantable pump system is a sophisticated medical therapy for those who suffer from chronic, severe pain who are unresponsive to traditional medical therapy. This article describes the patient selection and monitoring process and reviews available intrathecal medications and combinations.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16499827     DOI： 10.1007/s11916-006-0006-2

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN： 1534-3081


  42 in total

1.  Ziconotide for the treatment of severe spasticity after spinal cord injury.

Authors:  B Ridgeway; M Wallace; A Gerayli
Journal:  Pain       Date:  2000-03       Impact factor: 6.961

2.  Management of intra-thecal baclofen overdose.

Authors:  S Rushman; I McLaren
Journal:  Intensive Care Med       Date:  1999-02       Impact factor: 17.440

Review 3.  Spinal analgesics.

Authors:  Hollie Nguyen; Jason E Garber; Samuel J Hassenbusch
Journal:  Anesthesiol Clin North Am       Date:  2003-12

4.  Intrathecal acetyl cholinesterase inhibitors produce analgesia that is synergistic with morphine and clonidine in rats.

Authors:  S E Abram; R P Winne
Journal:  Anesth Analg       Date:  1995-09       Impact factor: 5.108

Review 5.  Evaluation of patients for implantable pain modalities: medical and behavioral assessment.

Authors:  J Prager; M Jacobs
Journal:  Clin J Pain       Date:  2001-09       Impact factor: 3.442

6.  The efficacy of intrathecal neostigmine, intrathecal morphine, and their combination for post-cesarean section analgesia.

Authors:  C J Chung; J S Kim; H S Park; Y J Chin
Journal:  Anesth Analg       Date:  1998-08       Impact factor: 5.108

7.  Long-term intrathecal baclofen infusion for treatment of spasticity.

Authors:  R D Penn; J S Kroin
Journal:  J Neurosurg       Date:  1987-02       Impact factor: 5.115

8.  Intrathecal baclofen in hereditary spastic paraparesis.

Authors:  J M Meythaler; W D Steers; S M Tuel; L L Cross; D C Sesco; C S Haworth
Journal:  Arch Phys Med Rehabil       Date:  1992-09       Impact factor: 3.966

Review 9.  The use of intrathecal midazolam in humans: a case study of process.

Authors:  Tony L Yaksh; Jeffrey W Allen
Journal:  Anesth Analg       Date:  2004-06       Impact factor: 5.108

Review 10.  Spinal drug delivery.

Authors:  T S Grabow; D Derdzinski; P S Staats
Journal:  Curr Pain Headache Rep       Date:  2001-12
View more
  1 in total

1.  Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke.

Authors:  Shih-Yen Tsai; Tiffanie M Markus; Ellen M Andrews; Joseph L Cheatwood; April J Emerick; Anis K Mir; Martin E Schwab; Gwendolyn L Kartje
Journal:  Exp Brain Res       Date:  2007-08-24       Impact factor: 1.972
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.